Forskolin potently activates all cloned mammalian adenylyl cyclases except type IX by interacting with two homologous cytoplasmic domains (C 1 and C 2 ) that form the catalytic core. A mutational analysis of the IIC 2 protein (C 2 domain from type II adenylyl cyclase) and forskolin analogs suggests that Ser942 interacts with the 7-acetyl group of forskolin. The C 1 /C 2 complex has only one forskolin, one ATP, and one binding site for the ␣ subunit of the G protein that stimulates adenylyl cyclase (G s␣ ) and its structure may be modeled using the three-dimensional structure of (IIC 2 /forskolin) 2 . The Ser942 mutation defines which forskolin in the (IIC 2 /forskolin) 2 structure exists in C 1 /C 2 complex. Thus, the forskolin-binding site is close to the G s␣ -binding site but distal (15-20Å) from the catalytic site. Mutation from Leu912 of IIC 2 protein to tyrosine or alanine severely reduces G s␣ activation and completely prevents forskolin activation. The corresponding residue of Leu912 is Tyr1082 at type IX isoform of adenylyl cyclase. Similar to recombinant type IX enzyme, soluble adenylyl cyclase derived from mouse-type IX adenylyl cyclase is sensitive to G s␣ activation but not to forskolin. Changing Tyr1082 to leucine makes soluble type IX adenylyl cyclase forskolin-responsive.
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The diterpene, forskolin, is a cardiac-enhancing drug isolated from the Indian plant Coleus forskolhii and is a potent activator of nearly all mammalian adenylyl cyclases (Seamon and Daly, 1986; Laurenza et al., 1989) . Forskolin has been immobilized for the affinity purification of the detergentsolubilized adenylyl cyclase, leading to success in cloning the genes that encode mammalian adenylyl cyclases (Pfeuffer et al., 1985; Krupinski et al., 1989) . The analysis of nine types of recombinant mammalian adenylyl cyclases reveals that all adenylyl cyclases except type IX can be potently activated by forskolin (Premont et al., 1996; Tang et al., 1997) .
1 Mammalian adenylyl cyclases consist of two homologous cytoplasmic domains (C 1 and C 2 ), each following one transmembrane domain (M 1 and M 2 ) (Tang et al., 1997; Taussig and Gilman, 1995; Sunahara et al., 1996) . The two cytoplasmic domains form the catalytic core; forskolin binds and activates these core domains directly Yan et al., 1996; Whisnant et al., 1996; Sunahara et al., 1997; Scholich et al., 1997) .
The three dimensional structure of the IIC 2 /forskolin dimer, which resembles that of the C 1 /C 2 complex, has been solved recently (Zhang et al., 1997; Yan et al., 1997a) (Fig. 1) . The IIC 2 structure consists of a ␤␣␤␤␣␤ substructure that is similar to the palm domain of prokaryotic DNA polymerases including Escherichia coli DNA polymerase I and Thermus aquaticus (Taq) polymerase (Artymiuk et al., 1997) . The C 1 /C 2 complex binds only one G s␣ , one ATP, and one forskolin molecule based on equilibrium dialysis of the C 1 and C 2 domains of type V and type II adenylyl cyclases, respectively . The G s␣ -binding site of adenylyl cyclase has been mapped to a region formed by the ␣2 and ␣3/␤4 region of C 2 domain and the amino terminus of the C 1 domain. The G s␣ -binding site is distal (20 -30Å) to the catalytic (also ATP-binding) site, which is defined by our mutational analysis (Yan et al., 1997b; Artymiuk et al., 1997) . The (IIC 2 /forskolin) 2 structure has two forskolin molecules, which lie in the hydrophobic pocket in the ventral cleft of the IIC 2 dimer interface. Nine of 13 residues in the C 2 domain involved in the binding of forskolin to the IIC 2 dimer are conserved in the C 1 domain. It remains to be determined which of two forskolin molecules in (IIC 2 /forskolin) 2 binds at the C 1 /C 2 complex and whether the interaction between forskolin and the IIC 2 dimer can serve as a model to study how forskolin binds to the C 1 /C 2 complex. In this article, we use mutational analysis to address both questions.
Experimental Procedures
Materials. Forskolin and its analogs were from Calbiochem (La Jolla, CA); restriction enzymes and Vent DNA polymerase were from New England Biolabs (Beverly, MA); Bradford reagent was from Bio-Rad (Hercules, CA); the enhanced chemiluminescence system was from Amersham (Arlington Heights, IL); and Ni-NTA resin was from Qiagen (Chatsworth, CA).
Plasmids. The plasmids used to express mutant forms of IIC 2 were constructed as described except for those used to express IIC 2 -L912A and IIC 2 -L912Y, which were done using Quickchange (Stratagene, La Jolla, CA) (Yan et al., 1997a) . A plasmid used to express IXC 1 protein was constructed by performing polymerase chain reaction using the primers ATTACCATGGGGCAAA-GATCTGGAAGTAGAG and TGGGAAGCTTGAATTAATAATCTT-TCATCAGGCTGTC, pSK-AC9 as the template, and Vent DNA polymerase. The 1.3-kilobase polymerase chain reaction product was isolated from agarose gel, digested with EcoRI and HindIII, and cloned into pProEx-HAH6 that had been digested with the same enzymes, resulting in the construct pProExHAH6-IXC 1 . For the expression of IXC 2 , the 1.4 kb NcoI/XhoI fragment was cut out of pSK-AC9 and ligated to pProEx-HAH6 that was digested with the same enzyme. Because the IXC 2 coding sequences in the resulting plasmid were out of frame compared with those that encoded the hexo-histidine tag, the resulting plasmid and the primer CCGGATTACGCCGGAGATGTGGAGGCCGAC were used to do site-directed mutagenesis for the construction of the plasmid that could be used to express IXC 2 , resulting in pProExHAH6-IXC 2 (Kunkel, 1985 ). Kunkel's method was used to construct IXC 2 mutants from pProExHAH6-IXC 2 as the template; oligonucleotides used for mutagenesis contained 10-12 complementary nucleotides flanking each side of the target codon(s), which were replaced with the appropriate codon (Kunkel, 1985) . Mutations were confirmed by dideoxyl nucleotide sequencing of phagemid DNA.
Expression and purification of recombinant C 1 and C 2 protein from E. coli. The expression of wild-type and mutant forms of hexo-histidine-tagged IC 1 and IIC 2 has been described previously (Yan et al., 1996) . The conditions for expressing hexo-histidinetagged IXC 1 and IXC 2 wild-type and mutant proteins in E. coli BL21(DE3) cells were the same for expressing IC 1 and IIC 2 (Yan et Fig. 1 . The interaction of IC 2 /IIC 2 complex with forskolin. The IC 1 /IIC 2 /forskolin structure is based on the three dimensional structure of (IIC 2 / forskolin) 2 (Zhang et al., 1997) . The catalytic and G s␣ -binding sites are based on mutational analysis (Yan et al., 1997a (Yan et al., , 1997b . ., 1996) . Both IXC 1 and IXC 2 proteins were purified using the Ni-NTA column and Q-sepharose column and IXC 1 was further purified by Superdex 200 column. The conditions and buffers used in purification of IXC 1 and IXC 2 were similar to the purification of IC 1 and IIC 2 (Yan et al.,1996) . The G s␣ -stimulated activity was used to determine the protein peak in the fractions from Q-sepharose and Superdex 200 columns (Pharmacia, Piscataway, NJ). The concentration of proteins was determined using Bradford reagent and bovine serum albumin as standard (Bradford, 1976) .
Adenylyl cyclase assay. The purification of hexo-histidinetagged G s␣ was performed as described previously (Lee et al., 1994) . G s␣ was activated by 50 M AlCl 3 and 10 mM NaF, and adenylyl cyclase assays were performed at 30°for 20 min (Yan et al., 1996; Salomon et al., 1976) .
Results
Ser942 of IIC 2 protein is important in interacting with forskolin. We have constructed forskolin-and G s␣ -sensitive soluble adenylyl cyclase from the C 1 domain of type I enzyme and the C 2 domain of type II enzyme; such a system is used in analyzing the forskolin-binding site (Tang and Gilman, 1995a; Yan et al., 1996) . All adenylyl cyclases except type IX are potently activated by forskolin (Premont et al., 1996) .
1 Sequence analysis reveals that eight amino acids in the C 2 domain are absolutely conserved among forskolinsensitive type I to VIII enzyme, and rutabaga adenylyl cyclases, but differ in forskolin-insensitive mouse-type IX enzyme (Yan et al., 1997a) . By mutating six of these eight residues to alanine in the C 2 domain of type II enzyme (IIC 2 ), we found that E. coli lysates containing mutant IIC 2 -S942A had relatively normal stimulation by G s␣ , but had moderately reduced activation by forskolin 2 (not shown). This difference is not caused by low expression because immunoblot analysis indicated that lysate containing IIC 2 -S942A had similar amounts of IIC 2 compared with wild-type IIC 2 (not shown). Mutant IIC 2 -S942A was purified to homogeneity ( Fig. 2A) . The purified protein was tested for its G s␣ and forskolin activation when the purified IC 1 protein was added. IIC 2 -S942A had nearly normal G s␣ activation but about a 6-fold reduction in forskolin activation (Fig. 3A, B) . In the presence of submaximal G s␣ , the maximal forskolin-stimulated activity of IIC 2 -S942A was similar to that of wild-type IIC 2 (Fig.  3C) . The 6-fold reduction in forskolin activation of IIC 2 -S942A may be related to the apparent reduced affinity indicated by the 6-fold increase in EC 50 value (0.3 and 1.7 M for wild type IIC 2 and IIC 2 -S942A, respectively; Fig. 3C ). G s␣ activation of the IC 1 /IIC 2 complex can be greatly enhanced by forskolin; thus, the reduction in forskolin activation should result in reduced G s␣ activation. As expected, IIC 2 -S942A did have reduced G s␣ activation when submaximal forskolin (2 M) was present (Fig. 3D) .
The hydroxyl groups at the 1␣-and 9␣-positions and the acetoxyl group at the 7␤-position of forskolin are crucial for forskolin activation of adenylyl cyclase (Sutkowski et al., 1994) . The forskolin analog 1-deoxyforskolin did not activate IC 1 ϩIIC 2 complexes; 7-deacetyl-and 9-deoxyforskolin had reduced potency (Fig. 3 , E and F; not shown for 1-deoxyforskolin). These results are similar to those observed with membrane-bound adenylyl cyclase (Sutkowski et al., 1994) . When mixed with IC 1 , activation of IIC 2 -S942A by 9-deoxyforskolin was reduced about 3-7-fold compared with that of wild-type IIC 2 , similar to the observed reduction in activation by forskolin. In contrast, the activation of IIC 2 -S942A by 7-deacetylforskolin was only about 2-3-fold less than that of wild-type IIC 2 . This corroborates the hydrogen bonding between the 7␤-acetyl group of forskolin and the hydroxyl group of Ser942 observed in the IIC 2 /forskolin crystal structure (Zhang et al., 1997) . The (IIC 2 /forskolin) 2 structure indicates that the 7-acetyl group of forskolin forms hydrogen bonds with both the main and side chain of Ser942 (Zhang et al., 1997) (Fig. 1) . The model predicts that a Ser942-to-proline mutation would disrupt hydrogen bonding in both the main and the side chains to the 7-acetyl group of forskolin. Thus, such a mutation should have a profound reduction in forskolin activation without a reduction in G s␣ activation. IIC 2 -S942P had 25-30% reduction in G s␣ activation when either lysate containing IIC 2 -S942P or purified mutant protein was used (Fig.  3B) . In contrast to the moderate reduction in G s␣ stimulation, 2 The six mutated residues are Q880, S881, L912, S942, S990, and N992. We did not test A1012 and S1032 of IIC 2 (both are threonine in the type IX enzyme).
3 The observation suggesting the interaction between Ser942 of the type II enzyme and the 7-acetyl group of forskolin was obtained without prior knowledge of the molecular structure of IIC 2 /forskolin dimer. A, Purified IIC 2 mutant proteins (2.5 g) were electrophoresed on 13% SDS-PAGE and stained with Coomassie Blue. B, High-speed supernatants of lysate from E. coli BL21(DE3) cells (15 g of that containing IXC 1 and 0.2 g of those containing IXC 2 and IXC 2 mutant proteins) were prepared 3 hr after induction by isopropyl-1-thio-galactopyranoside, electrophoresed on 13% SDS-PAGE and immunoblotted with a monoclonal antibody, 12CA5. C, Purified IXC 1 (5 g), IXC 2 , and its mutant proteins (2.5 g) were electrophoresed on 13% SDS-PAGE and stained with Coomassie Blue. IIC 2 -S942P had a 20-to 40-fold reduction in forskolin and 9-deoxyforskolin stimulation, substantially more than that of IIC 2 -S942A. IIC 2 -S942P had about 25% reduction in maximal forskolin stimulation when activated with submaximal G s␣ (Fig. 3C) . The reduction in forskolin activation is obvious in the EC 50 values, not in the V max values ( Fig. 3C ; the EC 50 values for wild-type IIC 2 and IIC 2 -S942P were 0.3 and 5.8 M, respectively, and V max values were 2.5 and 2.1 mol/min/ mg, respectively). In the presence of forskolin (2 M), IIC 2 -S942P had significant reduction in G s␣ activation, presumably because of the drastically reduced forskolin activation of IIC 2 -S942P mutant (Fig. 3D) .
Based on equilibrium dialysis of the VC 1 /IIC 2 complex, there is only one forskolin in the C 1 /C 2 complex . Our data show that S942 of IIC 2 is essential in interacting with the 7-acetyl group of forskolin. Thus, the forskolin molecule binds the site that is close to the G s␣ -binding site but distal to the ATP-binding site (Fig. 1) . Based on the (IIC 2 /forskolin) 2 model, IIC 2 -S942A or IIC 2 -S942P should not have significantly reduced activation by 7-deacetylforskolin relative to wild-type IIC 2 . However, we observed 2-and 10-fold reductions when IIC 2 -S942A and IIC 2 -S942P were stimulated by 7-deacetylforskolin, respectively. Possible reasons for such reductions include changes in the local conformation at the forskolin-binding site by Ser942 to the alanine or proline mutations and the structural differences at the forskolin-binding site between the C 1 /C 2 complex and the IIC 2 dimer. Further experiments are required to resolve this discrepancy.
Mutations near the forskolin-binding site affect both G s␣ and forskolin activation of C 1 /C 2 complex. We constructed and analyzed two sets of IIC 2 mutants that had mutations surrounding forskolin (Fig. 1) . Tyr899 is conserved among all the mammalian adenylyl cyclases. Based on the IC 1 /IIC 2 model using (IIC 2 /forskolin) 2 structure, Tyr899 is located at the C 1 /C 2 interface and is in contact with 13-methylenyl and 13-methyl groups of forskolin and Trp421 of C 1 protein (Fig. 1) . Thus, mutation at Tyr899 of IIC 2 is likely to affect both interaction with IC 1 and forskolin. We constructed a IIC 2 mutant with the mutation of Tyr899 to Leu, and IIC 2 -Y899L was expressed normally (not shown). As expected, the purified IIC 2 -Y899L protein had substantially higher reduction in forskolin stimulation (ϳ40-fold) than in G s␣ activation (6-fold) compared with wild-type IIC 2 (Fig. 4,  A and B) . Submaximal G s␣ partially rescued forskolin activation (Fig. 4, A and C) . We also mutated Phe898, which is conserved among all mammalian adenylyl cyclase and seems to be involved in coordinating the G s␣ -binding site. To our surprise, mutation of Phe898 to Leu drastically reduced both G s␣ and forskolin activation of IIC 2 -F898 (Fig. 4, A and B) . IIC 2 -F898 seemed to have reduced affinity to forskolin depicted by the increased EC 50 value of forskolin activation in the presence of submaximal G s␣ (Fig. 4C) . The purified IIC 2 protein that had mutated both Tyr899 and Phe898 to Leu had nearly no enzyme activity (Fig. 4) .
Leu912 is one of eight amino acid residues that are conserved among forskolin-sensitive adenylyl cyclases but differ in the forskolin-insensitive type IX enzyme. Based on the (IIC 2 /forskolin) 2 structure, Leu912 is located at the interface of C 1 /C 2 complex and 6Å away from forskolin. Thus, it is involved in coordinating the binding of Tyr899 of IIC 2 and Trp421 of IC 1 to forskolin (Fig. 1) . The corresponding residue of Leu912 in type II enzyme is Tyr1082 in the type IX enzyme. Tyrosine substitution of Leu912 in the IIC 2 protein should cause steric conflicts between the substituted residue and Tyr899 and Trp421 and consequently disturb the structure of the forskolin-binding pocket (Fig. 1) . We had mutated Leu912 of IIC 2 to alanine or tyrosine and both IIC 2 -L912A and IIC 2 -L912Y could be expressed and purified similarly to wild-type IIC 2 (Fig. 2A) . When mixed with IC 1 , both IIC 2 -L912A and IIC 2 -L912Y had Ͼ 100-fold reduction in G s␣ -stimulated activity. Both mutant proteins showed little forskolin stimulation unless G s␣ (0.2 M) was present (Fig. 4 , B and C).
Tyr1082-to-leucine mutation converts type IX adenylyl cyclase to be forskolin-sensitive. Type IX adenylyl cyclase is forskolin-insensitive. One or more mutations that render type IX enzyme sensitive to forskolin would highlight the residue(s) important for forskolin activation. To find such residue(s), we first constructed the C 1 and C 2 domains from type IX adenylyl cyclase (IXC 1 and IXC 2 , respectively) and tested whether they could form the functional enzyme and exhibit the proper biochemical properties.
4 IXC 1 and IXC 2 proteins were both tagged with the influenza hemoagglutinin epitope, and immunoblot analysis showed that IXC 1 and IXC 2 proteins had the expected 50-and 42-kDa size (Fig. 2B) . Small molecular-weight proteins were seen in the lysates containing IXC 1 and IXC 2 proteins, presumably proteolytic products. E. coli lysates containing either IXC 1 or IXC 2 protein alone had no detectable adenylyl cyclase activity. However, significant G s␣ -stimulated enzyme activity was detected when the two lysates were mixed together (not shown). Lysates containing IXC 1 and IXC 2 protein did not exhibit forskolin sensitivity with or without G s␣ (not shown). This result is consistent with the observation that type IX adenylyl cyclase is G s␣ -sensitive, but is insensitive to stimulation by forskolin (Premont et al., 1996) . 1 IXC 2 protein was expressed in at least 100-fold greater quantity than IXC 1 protein based on immunoblot analysis. IXC 2 protein could be purified to near homogeneity with the use of a Ni-NTA column and then a Q-sepharose column. The yield of IXC 2 protein was about 6 mg/liter of E. coli culture (Fig. 2C) . The purification of IXC 1 protein was less effective. After running the lysates through three columns (Ni-NTA, Q-sepharose, and fast performance liquid chromatography Superdex 200), 50 g of IXC 1 protein, which was only about 20% pure, could be obtained from a liter of E. coli culture (Fig. 2C) .
5 Thus, the specific activity of the purified IXC 1 and IXC 2 mixed proteins was only about 15-fold higher than that of E. coli lysates. Similar to the results obtained from E. coli lysates, the purified IXC 1 and IXC 2 proteins could be activated by G s␣ but not by forskolin (Fig. 5A) .
As described above, mutations at Ser942 and Leu912 could affect the forskolin-stimulated activity of IC 1 /IIC 2 complex. The corresponding position for Ser942 and Leu912 of type II adenylyl cyclase is Ala1112 and Y1082, respectively, in type IX adenylyl cyclase. Thus, we tested whether IXC 1 ϩIXC 2 proteins could become forskolin-sensitive by changing Ala1112 to serine, Y1082 to leucine, and both simultaneously. All IXC 2 -A1112S, IXC 2 -Y1082L, and IXC 2 -Y1082L, A1112S were expressed in similar amounts compared with that of wild-type IXC 2 and could be purified to near homogeneity (Fig. 2, B and C) . Mixed IXC 1 and all three IXC 2 proteins were stimulated by G s␣ using either E. coli lysates or purified proteins (Fig. 5A ). Purified IXC 2 -Y1082L, A1112S protein mixed with IXC 1 had weak but detectable forskolin stimulation, whereas both IXC 2 -Y1082L and IXC 2 -A1112S proteins mixed with IXC 1 did not (Fig. 5A ). In the presence of submaximal concentration of G s␣ , both IXC 2 -Y1082L and IXC 2 -Y1082L, A1112S, when mixed with IXC 1, had 10-to 15-fold stimulation by forskolin, whereas wild-type IXC 2 had no observable forskolin stimulation (Fig. 5) . Thus, Tyr1082 to leucine mutation converts soluble type IX adenylyl cyclase into forskolin-sensitive enzyme.
Discussion
Soluble adenylyl cyclases derived from membrane-bound adenylyl cyclases have proven to be an excellent tool for studying the biochemical properties of adenylyl cyclase. The C 1 and C 2 domains from their natural combination or from 4 IXC 1 and IXC 2 proteins contain aa 320 -741 and aa 1011-1353 of mousetype IX adenylyl cyclase, respectively.
5 IXC 1 protein was not purified further because it was rather unstable and the enzyme activity was not preserved by quick freezing, even with 20% glycerol. different isoforms (chimeric C 1 /C 2 ) can form functional soluble enzymes Yan et al., 1996; Whisnant et al., 1996; Dessauer and Gilman, 1996; Scholich et al., 1997; Yan et al., 1997a; Sunahara et al., 1997) . 6 The threedimensional structure of the IIC 2 dimer/forskolin has been solved, providing a structural model of the catalytic domain of adenylyl cyclases (Zhang et al., 1997) . Our mutational analysis for the G s␣ activation site of IC 1 /IIC 2 protein indicates that the structure of the IIC 2 dimer is a reasonable representation of the IC 1 /IIC 2 protein (Yan et al., 1997a) . In this paper, we show that the IIC 2 /forskolin model has successfully predicted the essential roles for Ser942, Tyr899, and Leu912 in forskolin sensitivity in either the IC 1 /IIC 2 or IXC 1 /IXC 2 model, indicating that the forskolin-binding region at the C 2 domain predicted from the IIC 2 /forskolin model is reasonably accurate. Forskolin binds to the site that is close to G s␣ , which allows forskolin to synergistically enhance G s␣ activation. Although the forskolin binding site is 15-20Å away from ATP-binding site, forskolin does affect ATP binding. Forskolin stimulation in the absence of manganese ion increases the K m value of Mg-ATP 10-fold for the native and recombinant type I, II, V, and rutabaga adenylyl cyclases; the molecular mechanism remains elusive .
Our result shows that Ser942 of type II adenylyl cyclase modulates the enzyme's affinity for forskolin. Tyr1082 plays an active role in preventing type IX adenylyl cyclase from being sensitive to forskolin, although Ala1112 (the residue corresponding to Ser942 of type II enzyme) may also be involved. It is interesting to note that the type IX enzyme homolog from Drosophila melanogaster is forskolin-sensitive and the corresponding Tyr1082 and Ala1112 of D. melanogaster type IX enzyme are leucine and serine, respectively (Iourgenko et al., 1997) . These facts lead to several questions. Why are the hydrophobic forskolin pockets conserved among eight isoforms of mammalian adenylyl cyclases (type I to XIII) and several fruit fly adenylyl cyclases? Why does mouse-type IX enzyme have a different forskolin-binding pocket and its fruit fly homolog does not? One obvious answer is the existence of endogenous lipophilic compound(s) that can mimic the function of forskolin; if such a molecule exists, it remains to be discovered.
